Synthetic tuberculosis vaccines could save millions of lives
Washington, August 29 (ANI): Cases of one of the world's deadliest diseases-tuberculosis-are spiralling at an alarming rate, due to the ineffectiveness of the existing vaccines, a new study including an Indian-origin researcher has revealed.
"Tuberculosis is a global health threat, and it is a highly communicable disease that may influence practically anyone and everyone," says senior author Javed Agrewala of the CSIR-Institute of Microbial Technology in Chandigarh, India.
"There is a serious need and challenge for the scientific community to develop alternative vaccination approaches for the control of the disease."
Tuberculosis is a bacterial infection caused by Mycobacterium tuberculosis (Mtb). About one third of the world's population is infected with Mtb, which causes about two million deaths each year. Vaccines may be the best strategy for controlling tuberculosis, but the only available vaccine-Bacillus Calmette-Guerin (BCG)-does not reliably prevent the disease in adults, especially in regions where tuberculosis is endemic.
In the review, Agrewala explains that BCG does not work well in these regions because exposure to prevalent mycobacterial strains triggers the production of antibodies that counteract the vaccine. In addition, infections with parasitic worms called helminths interfere with protective immune responses induced by BCG.
To overcome these limitations, Agrewala proposes the use of novel vaccines called lipidated-promiscuous-peptide vaccines. These synthetic vaccines are safer than BCG because they do not contain infectious material. Moreover, they generate long-lasting, protective immune responses and are not influenced by pre-existing antibodies. This type of vaccine strategy has already proven to be successful in an animal model of tuberculosis and is being tested in human clinical trials for other infectious diseases and cancer.
"We believe that lipidated-promiscuous-peptide vaccines have all the essential qualities that can make them successful in tuberculosis-endemic countries," Agrewala says.
"Such vaccines can impart better protection than BCG and will have a long-reaching positive impact on millions of people."
The study was recently published in Trends in Molecular Medicine. (ANI)
Read More: Sector 14 Po Chandigarh | Sector 15 Chandigarh | Sector 16 Po Chandigarh | Chandigarh Gpo | Sector 18 Po Chandigarh | Govt Press Chandigarh | Sector 19 Po Chandigarh | Sector 26 Po Chandigarh | Sector 21 Po Chandigarh | Sector 22 Po Chandigarh | Sector 34 Po Chandigarh | Sector 23 Po Chandigarh | Sector 29 Po Chandigarh | Sector 30 Po Chandigarh | Sector 60 Chandigarh | Sector 62 Po Chandigarh | Sector 65 Po Chandigarh | Sector 71 Po Chandigarh | Indian Institute Of Technology | Central Institute of Indian Language
PAIN OF LOVE IS VERY SWEET, SAYS RANBIR KAPOOR
May 21, 2013 at 12:54 PM
Veena Promotes Zindagi 50-50 by distributing condoms in a red light area
May 21, 2013 at 12:48 PM
BALIKA VADHU___S ANANDI TO BRING TRUCE BETWEEN MAHI AND SANCHI
May 21, 2013 at 12:44 PM